retroperitoneal cancer: An organ system cancer located_in the retroperitoneal space that is manifested in retroperitoneal space in the abdominal cavity behind the peritoneum.
Benign neoplasm of soft tissue of retroperitoneum and peritoneum
DOID EFO Endpoint Browser PheWeb
CD2_BENIGN_RETROPERITONEUM_PERITONEUM
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
182 |
4. Check minimum number of eventsNone |
182 |
5. Include endpointsNone |
182 |
6. Filter based on genotype QC (FinnGen only) |
182 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D10-D36
- Name in latin
- Neoplasma benignum telae mollis spatii retroperitonealis et/sive peritonei
Similar endpoints
↥List of similar endpoints to
Benign neoplasm of soft tissue of retroperitoneum and peritoneum
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm of soft tissue of retroperitoneum and peritoneum
- Benign neoplasms
- Benign neoplasms
- Neoplasms
- Any operation in hilmo
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1295 | 851 | 432 |
| Only index persons | 1064 | 738 | 326 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.02 | 0.01 |
| Only index persons | 0.02 | 0.03 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 56.26 | 53.03 | 62.62 |
| Only index persons | 53.21 | 50.40 | 59.57 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 182 | 132 | 50 |
| Unadjusted period prevalence (%) | 0.04 | 0.04 | 0.02 |
| Median age at first event (years) | 55.96 | 52.16 | 66.01 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 176
- Matched controls
- 1761
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D20.0
ICD-10 Finland
Benign neoplasm: Retroperitoneum
+∞
126.9
106
*
D20.1
ICD-10 Finland
Benign neoplasm: Peritoneum
+∞
56.3
51
*
D48.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Retroperitoneum
187.0
16.8
17
*
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
9.0
11.0
23
29
21170
ICD-8 Finland
Benign neoplasm of other parts of digestive system, Peritoneum and retroperitoneal tissue
+∞
10.5
10
*
KKB10
NOMESCO Finland
Excision of retroperitoneal tumour
+∞
10.5
10
*
JAH00
NOMESCO Finland
Laparotomy
11.0
9.8
18
18
JAH01
NOMESCO Finland
Laparoscopy
6.1
9.0
24
44
D20
ICD-10 Finland
Benign neoplasm of soft tissue of retroperitoneum and peritoneum
+∞
8.4
8
*
UJF32
NOMESCO Finland
Coloscopy
2.8
8.0
63
294
UKC02
NOMESCO Finland
Cystoscopy
3.5
7.9
39
134
WX302
NOMESCO Finland
Thoracal epidural anesthesy
5.7
7.5
21
41
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
12.8
7.2
12
10
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
10.7
7.2
13
13
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.5
7.1
34
114
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.3
6.5
86
518
2118X
ICD-9 Finland
Benign neoplasm of other parts of digestive system, Retroperitoneum and peritoneum[NEOPLASMA BENIGNUM ALIUD SPATII RETROPERITON ET PER]
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
33
105
3.62
9.04
3.8
2.4
u/ml
49.0
41.7
0.15
33
100
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
44
176
2.98
8.29
3.0
4.2
ug/l
5.7
8.9
0.47
33
141
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
67
338
2.55
8.03
3.1
2.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
79
467
2.22
6.33
3.3
2.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
100
686
2.02
5.10
4.6
3.9
—
—
—
0
0
(40761535) Cells panel - Urine sediment
26
116
2.45
3.86
2.1
3.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
85
592
1.82
3.79
10.2
7.7
inr
1.2
1.2
0.17
17
182
(3033658) Prothrombin time (PT) actual/Normal
60
377
1.88
3.70
3.6
3.3
%
93.0
91.4
0.17
60
367
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
68
446
1.84
3.66
3.5
3.1
ng/l
1361.7
1329.7
0.03
60
376
(3013650) Neutrophils [#/volume] in Blood by Automated count
112
856
1.80
3.59
10.8
9.9
e9/l
4.4
4.0
0.69
92
751
(3026493) Urate [Moles/volume] in Serum or Plasma
59
376
1.84
3.45
3.3
2.7
umol/l
327.5
7311.3
2.28
52
311
(3020779) Urea [Moles/volume] in Serum or Plasma
23
104
2.39
3.32
7.9
4.5
mmol/l
9.5
9.6
0.02
23
96
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
40
227
1.98
3.30
2.9
2.7
e6/l
3.3
3.1
0.06
26
125
(3013707) Erythrocyte sedimentation rate by Westergren method
134
1096
1.84
3.27
5.3
3.9
mm/h
15.0
12.5
0.90
124
988
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
106
814
1.72
3.19
9.0
5.7
umol/l
11.5
10.7
0.44
97
765
(3019198) Lymphocytes [#/volume] in Blood
99
750
1.70
3.10
7.2
5.0
e9/l
2.0
2.0
0.04
86
665
(3004588) Protein electrophoresis panel - Serum or Plasma
22
101
2.34
3.08
2.5
2.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
53
339
1.79
3.02
1.7
1.7
mg/l
1.0
1.1
0.06
40
278
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
7
13
5.55
2.89
3.6
2.5
nmol/l
6.6
4.0
—
7
13
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
6
9
6.85
2.89
3.3
1.9
—
—
—
0
0
(3002256) Pathology report gross observation
34
191
1.96
2.88
1.3
1.3
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
138
1158
1.79
2.87
11.4
7.0
u/l
87.8
78.0
0.86
129
1069
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
73
521
1.67
2.78
3.7
2.9
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
86
641
1.65
2.77
2.3
2.1
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
95
728
1.64
2.73
7.3
5.0
e9/l
0.6
0.6
0.24
80
633
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
55
366
1.72
2.71
2.6
2.1
mg/l
2.7
3.2
0.91
48
309
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
39
235
1.84
2.68
2.7
2.5
e6/l
0.7
0.9
0.32
24
131
(3006315) Basophils [#/volume] in Blood
95
732
1.62
2.64
7.3
5.0
e9/l
0.0
0.0
0.24
81
634
(3045414) Leukocytes [Presence] in Urine
14
56
2.63
2.60
2.0
1.7
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
8
20
4.13
2.60
1.9
1.9
%
75.4
58.0
—
8
20
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
88
668
1.61
2.58
8.6
5.3
mmol/l
1.2
1.2
0.58
80
601
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
18
82
2.33
2.57
1.5
1.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
14
57
2.58
2.51
3.5
3.0
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
10
34
3.05
2.45
1.5
1.8
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
32
186
1.87
2.45
3.9
4.7
%
33.4
33.5
0.02
25
114
(3045142) Bone marrow Pathology biopsy report
6
12
5.13
2.42
2.3
1.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
76
578
1.54
2.11
4.4
3.6
ng/l
55.6
42.1
0.23
53
394
(3000991) Gas panel - Venous blood
20
104
2.04
2.10
8.5
7.8
—
—
—
0
0
(3013512) EKG study
62
451
1.57
2.09
4.1
3.8
—
—
—
0
0
(4281824)
7
20
3.60
2.07
1.3
1.0
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
95
761
1.52
2.06
8.0
5.6
e9/l
0.2
0.2
0.78
84
673
(3002030) Lymphocytes/100 leukocytes in Blood
89
707
1.51
1.98
8.3
5.3
%
27.5
27.7
0.08
84
657
(3000570) Elastase.pancreatic [Mass/mass] in Stool
11
45
2.54
1.97
2.0
1.3
ug/g
222.3
272.4
—
6
25
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
23
129
1.90
1.97
3.3
2.2
g/l
0.2
0.2
0.12
23
120
(3024928) Oxygen saturation in Venous blood
8
27
3.05
1.96
2.9
2.6
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
88
699
1.50
1.95
7.8
5.1
%
57.8
57.2
0.18
83
652
(4062490)
5
11
4.64
1.95
1.8
1.3
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
17
86
2.08
1.92
3.4
3.0
kpa
5.2
5.2
0.12
17
78
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
91
731
1.49
1.90
8.9
5.7
mmol/l
1.2
1.2
0.44
80
608
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
114
959
1.51
1.89
4.7
3.0
u/l
62.0
44.4
0.75
107
898
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
19
101
1.98
1.89
1.4
1.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
6
17
3.61
1.85
1.3
1.6
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
5
12
4.25
1.83
3.2
1.5
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
5
12
4.25
1.83
1.0
1.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
60
445
1.52
1.82
4.0
3.0
e6/l
17.1
208.3
0.72
45
342
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
40
270
1.62
1.82
1.2
1.3
iu/ml
13.0
31.2
1.76
11
88
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
6
18
3.41
1.76
1.2
1.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
6
18
3.41
1.76
1.8
1.0
—
—
—
0
0
(4035726)
24
142
1.79
1.75
1.5
1.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
8
30
2.74
1.74
1.6
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
20
112
1.88
1.73
1.3
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
5
13
3.92
1.72
3.2
1.5
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
86
693
1.46
1.72
8.8
5.5
%
8.7
8.7
0.00
79
646
(42870588) Differential panel, method unspecified - Blood
64
490
1.47
1.65
9.3
4.6
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
26
161
1.72
1.64
6.3
7.0
mmol/l
0.4
1.6
0.81
20
135
(3019225) pH of Specimen
23
138
1.76
1.61
5.1
3.7
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
6
20
3.07
1.59
1.7
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
14
72
2.02
1.53
1.3
1.2
—
—
—
0
0
(4146454)
5
15
3.40
1.53
2.4
2.9
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
12
58
2.14
1.53
1.5
2.7
g/l
1.3
0.8
0.19
12
50
(3022096) Basophils/100 leukocytes in Blood
83
676
1.42
1.52
8.3
5.1
%
0.8
0.7
1.85
78
627
(3023368) Bacteria identified in Blood by Culture
55
416
1.46
1.49
3.9
3.6
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
67
527
1.43
1.48
4.6
3.6
e6/l
32.0
66.3
0.97
46
369
(3006504) Eosinophils/100 leukocytes in Blood
84
688
1.41
1.48
8.4
5.1
%
3.4
2.7
1.33
79
638
(3052851) Hemolysis interference index of Serum or Plasma
9
39
2.37
1.45
3.8
3.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
7
29
2.47
1.40
1.9
1.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
45
331
1.48
1.40
2.0
1.8
pmol/l
257500425.9
477.5
0.49
40
273
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
68
1.98
1.37
1.5
2.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
128
1137
1.42
1.36
5.1
4.1
pmol/l
14.9
14.7
0.46
117
1024
(3014051) Protein [Presence] in Urine by Test strip
8
34
2.41
1.31
2.3
1.9
—
—
—
0
0
(3022145) Colonoscopy Study observation
27
180
1.59
1.30
1.1
1.3
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
52
399
1.42
1.29
4.0
2.8
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
5
18
2.83
1.29
1.2
1.7
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
45
337
1.45
1.27
2.8
3.8
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
13
70
1.92
1.27
3.0
3.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
158
1468
1.58
1.27
22.5
13.8
mg/l
25.4
22.9
0.44
140
1164
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
43
320
1.45
1.26
1.3
1.3
u/ml
0.6
1.8
1.10
12
84
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
8
36
2.28
1.26
1.1
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
9
45
2.05
1.25
1.0
1.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
31
216
1.52
1.24
3.0
1.9
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
8
38
2.15
1.20
1.5
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
35
253
1.47
1.18
1.2
1.3
u/ml
3.7
10.2
1.11
19
92
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
73
602
1.36
1.17
2.3
2.0
pmol/l
105.3
98.7
0.36
38
286
(3030467) Casts [#/volume] in Urine by Automated count
52
406
1.39
1.17
4.1
2.9
e6/l
0.7
0.5
0.18
38
301
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
0
35
0.00
1.16
0.0
2.7
—
61.2
—
0
23
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
20
2.54
1.16
1.8
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
8
40
2.05
1.13
1.8
1.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
161
1511
1.57
1.13
18.3
13.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
21
2.42
1.10
1.8
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
21
2.42
1.10
1.8
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
5
21
2.42
1.10
1.8
1.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
21
2.42
1.10
1.8
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
21
2.42
1.10
1.8
1.2
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
11
60
1.89
1.05
2.9
2.4
%
0.5
0.7
1.49
11
60
(40758558) Short blood count panel - Blood
47
369
1.37
1.02
9.4
7.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
86
739
1.31
1.01
4.0
3.9
estimate
0.0
0.0
0.00
13
130
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
27
192
1.48
1.00
8.6
6.7
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
10
54
1.90
0.98
2.2
1.5
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
10
54
1.90
0.98
1.6
2.6
g/l
39.5
37.8
—
10
47
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
5
23
2.21
0.98
5.0
3.2
u/ml
49.7
57.9
—
5
23
(3023511) Choriogonadotropin [Units/volume] in Urine
5
23
2.21
0.98
1.2
1.4
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
147
1367
1.39
0.96
6.1
4.9
mu/l
2.1
1.9
0.32
137
1237
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
11
62
1.82
0.96
1.5
2.4
g/l
10.0
10.0
0.00
11
54
(3037467) Urinalysis macro (dipstick) panel - Urine
112
1002
1.31
0.96
4.7
4.4
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
47
374
1.35
0.93
1.9
1.6
nmol/l
19.8
21.9
0.43
42
303
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
13
204
0.61
0.92
3.3
4.4
%
20.9
21.6
—
5
99
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
11
63
1.79
0.92
2.9
2.4
%
0.9
1.1
0.53
11
63
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
7
129
0.52
0.92
1.3
1.7
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
14
87
1.66
0.90
1.7
1.7
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
8
42
1.95
0.90
1.8
1.4
—
—
—
0
0
(3012544) pH of Venous blood
18
120
1.55
0.89
6.9
3.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
37
287
1.36
0.86
2.3
3.0
mmol/l
2.5
2.5
0.03
32
249
(3025159) Blasts/100 leukocytes in Blood
17
113
1.56
0.85
3.6
4.6
%
0.0
0.0
—
6
29
(3021601) Nitrite [Presence] in Urine by Test strip
84
732
1.27
0.85
5.5
5.2
estimate
0.0
0.0
0.00
13
138
(3049717) Cytology report of Urine Cyto stain
8
47
1.73
0.82
2.0
2.7
—
—
—
0
0
(3019060) Gas panel - Arterial blood
14
90
1.60
0.81
5.5
4.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
6
33
1.85
0.80
3.8
2.8
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
18
124
1.50
0.78
2.7
2.9
ml/min/173m2
72.3
67.5
—
6
50
(3017181) Myelocytes/100 leukocytes in Blood
18
124
1.50
0.78
3.8
4.4
%
0.9
0.9
—
7
38
(3007164) IgA [Mass/volume] in Serum or Plasma
38
301
1.33
0.78
1.8
1.4
g/l
2.1
2.5
0.65
21
176
(3021440) Promyelocytes/100 leukocytes in Blood
17
116
1.51
0.77
3.8
4.5
%
0.0
0.1
—
6
35
(3020891) Body temperature
9
54
1.70
0.76
7.2
3.6
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
7
38
1.88
0.74
1.0
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
10
60
1.71
0.73
1.7
1.9
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
10
60
1.71
0.73
1.3
1.6
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
9
56
1.64
0.73
1.0
1.0
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
7
39
1.83
0.73
1.6
2.3
mg/l
1.5
1.5
—
7
34
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
5
25
2.03
0.73
2.6
2.7
—
20.1
—
0
7
(3017143) Hepatitis C virus Ab [Presence] in Serum
19
135
1.45
0.72
1.7
1.4
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
72
628
1.24
0.70
3.3
2.2
nmol/l
80.9
78.5
0.30
64
545
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
37
299
1.30
0.67
4.2
3.7
ng/l
333.1
186.0
0.26
32
232
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
148
1403
1.29
0.65
19.4
13.2
ml/min/173m2
76.8
79.5
0.70
127
1139
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
30
238
1.31
0.62
2.1
1.8
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
27
211
1.33
0.61
3.5
1.8
s
27.3
29.3
2.03
27
205
(1617658) Protocol used for examination of sentinel lymph nodes
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
22
168
1.35
0.58
9.7
4.1
u/l
248.3
248.3
0.00
22
156
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
10
148
0.66
0.58
1.3
1.8
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
13
90
1.48
0.57
1.1
1.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
8
122
0.64
0.57
1.1
1.3
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
36
298
1.26
0.55
3.6
2.6
e6/l
3.6
5.5
1.06
27
268
(3044889) 12 lead EKG panel
110
1020
1.20
0.54
4.3
3.9
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
9
132
0.67
0.54
8.7
3.6
—
—
—
0
0
(3026782) Osmolality of Urine
35
291
1.25
0.51
3.3
2.7
mosm/kgh2o
509.5
531.1
0.19
26
251
(3002179) Metamyelocytes/100 leukocytes in Blood
15
110
1.40
0.50
4.0
4.5
%
0.3
0.6
—
6
24
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
7
48
1.48
0.47
2.3
4.9
mg/l
25.5
24.3
—
7
35
(3034860) Kappa light chains.free [Mass/volume] in Serum
7
48
1.48
0.47
2.3
4.8
mg/l
151.2
219.1
—
7
35
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
13
94
1.41
0.47
1.2
1.4
—
45.3
—
0
7
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
7
50
1.42
0.45
1.4
1.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
137
1306
1.20
0.45
21.5
15.3
%
38.6
39.6
0.89
94
943
(3037756) Immunofixation for Serum or Plasma
5
31
1.63
0.43
2.0
1.7
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
5
31
1.63
0.43
1.0
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
5
31
1.63
0.43
1.4
1.5
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
8
56
1.45
0.43
1.5
1.3
—
—
—
0
0
(3015736) pH of Urine
64
576
1.17
0.43
3.8
3.5
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
10
70
1.45
0.42
7.8
9.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
5
33
1.53
0.41
1.4
5.9
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
0
17
0.00
0.41
0.0
1.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
20
160
1.28
0.40
2.1
1.7
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
166
1617
1.30
0.40
32.0
20.8
e12/l
4.3
4.4
1.86
161
1559
(3010813) Leukocytes [#/volume] in Blood
166
1617
1.30
0.40
32.1
20.9
e9/l
7.0
6.6
1.34
160
1557
(3022621) pH of Urine by Test strip
14
106
1.35
0.40
2.6
2.8
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
21
257
0.79
0.40
1.7
1.4
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(4268621)
0
18
0.00
0.40
0.0
1.9
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
11
81
1.38
0.37
1.3
1.5
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
34
295
1.19
0.35
2.2
1.7
nmol/l
1219.4
1229.2
0.02
24
220
(3035350) Ketones [Presence] in Urine by Test strip
79
733
1.14
0.34
4.0
3.8
estimate
0.0
0.0
0.00
12
142
(3041096) Erythrocytes [Presence] in Urine by Automated
36
409
0.85
0.34
5.1
3.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
95
896
1.13
0.31
3.4
3.0
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
47
424
1.15
0.30
3.3
2.9
mmol/l
6.6
7.1
0.43
38
346
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
25
289
0.84
0.29
1.3
1.4
—
—
—
0
0
(4010399)
13
103
1.28
0.29
1.2
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
12
94
1.30
0.29
1.3
1.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
141
1365
1.15
0.29
6.1
5.6
mmol/mol
40.1
39.7
0.22
130
1272
(3021879) Hepatitis B virus core Ab [Presence] in Serum
11
85
1.31
0.28
1.7
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
47
426
1.14
0.28
4.3
3.9
mg/mmol
15.2
7.0
0.63
28
250
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
19
159
1.22
0.28
3.9
3.6
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
45
408
1.14
0.27
3.6
3.0
mg/l
88.8
372.2
0.65
28
250
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
8
67
1.20
0.26
2.3
2.1
u/l
38.0
41.5
—
8
58
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
11
137
0.79
0.25
1.5
2.0
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
19
161
1.20
0.25
2.2
1.6
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
141
1371
1.13
0.24
4.3
4.0
mmol/l
1.3
1.3
0.01
131
1251
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
37
1.36
0.23
1.0
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
147
1434
1.13
0.22
4.8
4.5
mmol/l
4.7
4.7
0.09
138
1318
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
5
40
1.26
0.22
2.0
1.6
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
5
41
1.23
0.22
10.4
4.1
—
—
—
0
0
(3016750) Collection duration of Urine
0
11
0.00
0.21
0.0
2.3
—
494.7
—
0
6
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.7
—
2.8
—
0
5
(3004775) Volume in Urine collected for unspecified duration
0
12
0.00
0.21
0.0
2.4
—
643.2
—
0
6
(40768797) Stomach Pathology biopsy report
24
212
1.15
0.21
1.2
1.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
6
48
1.26
0.20
1.0
1.8
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
14
0.00
0.20
0.0
1.1
—
32.2
—
0
9
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
16.0
—
984.2
—
0
14
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.0
—
228.3
—
0
9
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
23.6
—
1914.9
—
0
14
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.0
—
515.9
—
0
9
(3018418) pH of Serum or Plasma
49
457
1.10
0.18
7.6
3.8
ph
7.4
7.4
—
6
90
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
7
58
1.22
0.18
2.4
1.8
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
146
1429
1.11
0.18
5.1
4.6
mmol/l
5.8
5.9
0.24
137
1308
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
10
120
0.82
0.17
4.3
4.2
mmol/l
1.2
1.2
—
10
106
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
13
111
1.18
0.16
1.2
1.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
45
479
0.92
0.15
2.9
3.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
7
86
0.81
0.15
1.1
1.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
7
87
0.80
0.15
1.1
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
20
222
0.89
0.14
1.8
1.6
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
42
399
1.07
0.10
1.5
1.7
mmol/l
1.6
1.3
0.62
35
333
(42529406) Shigella sp [Presence] in Stool by Culture
6
55
1.09
0.09
1.2
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
6
55
1.09
0.09
1.2
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
6
55
1.09
0.09
1.2
1.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
18
166
1.09
0.08
2.2
1.8
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
8
73
1.10
0.07
3.0
2.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
8
91
0.87
0.07
1.1
1.7
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
67
653
1.04
0.06
12.0
9.4
e9/l
0.0
0.0
1.22
51
530
(3026008) Bacteria identified in Urine by Culture
51
495
1.04
0.06
3.1
3.0
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
19
179
1.07
0.05
1.9
1.5
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
144
1428
1.04
0.04
4.7
4.5
mmol/l
1.5
1.5
0.13
134
1305
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
11
118
0.93
0.03
1.7
1.7
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
39
381
1.03
0.02
1.5
1.4
—
—
—
0
0
(3000492) Spirometry study
13
123
1.06
0.01
1.3
1.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
56
568
0.98
0.01
4.5
4.0
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
146
1464
0.99
0.00
5.4
5.0
mmol/l
2.7
2.8
0.38
136
1337
(40760892) CBC W Ordered Manual Differential panel - Blood
34
341
1.00
0.00
4.9
4.7
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
41
407
1.01
0.00
4.1
4.0
estimate
0.0
0.0
0.00
13
135
(3000494) Fungus identified in Specimen by Culture
18
182
0.99
0.00
1.4
1.3
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
7.5
—
0
6
(3036071) Salmonella sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
5
52
0.96
0.00
1.0
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3004451) EKG impression Narrative
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
5
58
0.86
0.00
1.4
1.4
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
8
0.00
0.00
0.0
7.4
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(4034850)
5
52
0.96
0.00
13.8
10.4
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
8
0.00
0.00
0.0
4.5
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
1937.8
—
0
5
(3043410) Blood group antigens tested for on Red Blood Cells
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3000012) Reticulocyte production index
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
0
7
0.00
0.00
0.0
3.4
—
—
—
0
0
(44806420)
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
9
0.00
0.00
0.0
8.4
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
8
0.00
0.00
0.0
4.5
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_RETROPERITONEUM_PERITONEUM and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_RETROPERITONEUM_PERITONEUM | 2.385 [1.89, 3.01] | < 0.001 |
| Birth year | 0.993 [0.98, 1.0] | 0.1 |
During the follow-up period (1.1.1998 — 31.12.2019), 150 out of 605 females with CD2_BENIGN_RETROPERITONEUM_PERITONEUM died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_RETROPERITONEUM_PERITONEUM | 1.881 [1.45, 2.44] | < 0.001 |
| Birth year | 0.987 [0.98, 1.0] | 0.007 |
During the follow-up period (1.1.1998 — 31.12.2019), 136 out of 336 males with CD2_BENIGN_RETROPERITONEUM_PERITONEUM died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_RETROPERITONEUM_PERITONEUM.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.204% | 0.449% |
| 5 | 1.191% | 2.385% |
| 10 | 3.436% | 5.42% |
| 15 | 6.315% | 9.864% |
| 20 | 10.745% | 16.087% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_RETROPERITONEUM_PERITONEUM – Benign neoplasm of soft tissue of retroperitoneum and peritoneum
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data